Cited by 73Mitochondrial Function and PathologyMetabolism, Diabetes, and CancerATP Synthase and ATPases Research

The yeast mitochondrial pyruvate carrier is a hetero-dimer in its functional state

Open access
Tavoulari, Sotiria, Thangaratnarajah, Chancievan, Mavridou, Vasiliki, Harbour, Michael E, Martinou, Jean‐Claude, Kunji, Edmund RS·2019·The EMBO Journal

Abstract

The mitochondrial pyruvate carrier (MPC) is critical for cellular homeostasis, as it is required in central metabolism for transporting pyruvate from the cytosol into the mitochondrial matrix. MPC has been implicated in many diseases and is being investigated as a drug target. A few years ago, small membrane proteins, called MPC1 and MPC2 in mammals and Mpc1, Mpc2 and Mpc3 in yeast, were proposed to form large protein complexes responsible for this function. However, the MPC complexes have never been isolated and their composition, oligomeric state and functional properties have not been defined. Here, we identify the functional unit of MPC from Saccharomyces cerevisiae . In contrast to earlier hypotheses, we demonstrate that MPC is a hetero‐dimer, not a multimeric complex. When not engaged in hetero‐dimers, the yeast Mpc proteins can also form homo‐dimers that are, however, inactive. We show that the earlier described substrate transport properties and inhibitor profiles are embodied by the hetero‐dimer. This work provides a foundation for elucidating the structure of the functional complex and the mechanism of substrate transport and inhibition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.2018100785

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The MPC is a heterodimer composed of two subunits MPC1 and MPC2.

    “This transporter is a heterodimer composed of two subunits MPC1 and MPC2 (Tavoulari et al., 2019).”

    From Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease (2024) · cites this paper as Tavoulari et al., 2019

    The Results (Expression and purification of the yeast Mpc proteins) show that yeast Mpc1 and Mpc2 form a hetero-complex, but the paper selected Mpc1/Mpc3—not Mpc1/Mpc2—for direct determination of its dimeric state. The Discussion says the functional yeast carrier is a heterodimer and explicitly cautions that its results cannot safely establish the oligomeric state of mammalian MPCs. The unqualified claim therefore goes beyond what the paper establishes. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. Alexandrov AI, Mileni M, Chien EY, Hanson MA, Stevens RC (2008) Microscale fluorescent thermal stability assay for membrane proteins. Structure 16: 351– 359 18334210
  2. Bader DA, Hartig SM, Putluri V, Foley C, Hamilton MP, Smith EA, Saha PK, Panigrahi A, Walker C, Zong L, Martini‐Stoica H, Chen R, Rajapakshe K, Coarfa C, Sreekumar A, Mitsiades N, Bankson JA, Ittmann MM, O'Malley BW, Putluri N et al (2019) Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor‐driven prostate cancer. Nat Metab 1: 70– 85 PMC6563330 31198906
  3. Bakker EP, van Dam K (1974) The movement of monocarboxylic acids across phospholipid membranes: evidence for an exchange diffusion between pyruvate and other monocarboxylate ions. Biochem Biophys Acta 339: 285– 289 4827853
  4. ter Beek J, Duurkens RH, Erkens GB, Slotboom DJ (2011) Quaternary structure and functional unit of energy coupling factor (ECF)‐type transporters. J Biol Chem 286: 5471– 5475 21135102 PMC3037660
  5. Bender T, Pena G, Martinou JC (2015) Regulation of mitochondrial pyruvate uptake by alternative pyruvate carrier complexes. EMBO J 34: 911– 924 25672363 PMC4388599
  6. Buchan DW, Minneci F, Nugent TC, Bryson K, Jones DT (2013) Scalable web services for the PSIPRED Protein Analysis Workbench. Nucleic Acids Res 41: W349– W357 23748958 PMC3692098
  7. Chen Y, McCommis KS, Ferguson D, Hall AM, Harris CA, Finck BN (2018) Inhibition of the mitochondrial pyruvate carrier by tolylfluanid. Endocrinology 159: 609– 621 29126303 PMC5774852
  8. Colca JR, Tanis SP, McDonald WG, Kletzien RF (2014) Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases. Expert Opin Investig Drugs 23: 1– 7 24073940
  9. Compan V, Pierredon S, Vanderperre B, Krznar P, Marchiq I, Zamboni N, Pouyssegur J, Martinou JC (2015) Monitoring mitochondrial pyruvate carrier activity in real time using a BRET‐based biosensor: investigation of the Warburg effect. Mol Cell 59: 491– 501 26253029
  10. Corbet C, Bastien E, Draoui N, Doix B, Mignion L, Jordan BF, Marchand A, Vanherck JC, Chaltin P, Schakman O, Becker HM, Riant O, Feron O (2018) Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects. Nat Commun 9: 1208 29572438 PMC5865202
  11. Crichton PG, Harding M, Ruprecht JJ, Lee Y, Kunji ER (2013) Lipid, detergent, and Coomassie Blue G‐250 affect the migration of small membrane proteins in blue native gels: mitochondrial carriers migrate as monomers not dimers. J Biol Chem 288: 22163– 22173 23744064 PMC3724668
  12. Crichton PG, Lee Y, Ruprecht JJ, Cerson E, Thangaratnarajah C, King MS, Kunji ER (2015) Trends in thermostability provide information on the nature of substrate, inhibitor, and lipid interactions with mitochondrial carriers. J Biol Chem 290: 8206– 8217 25653283 PMC4375477
  13. Divakaruni AS, Wallace M, Buren C, Martyniuk K, Andreyev AY, Li E, Fields JA, Cordes T, Reynolds IJ, Bloodgood BL, Raymond LA, Metallo CM, Murphy AN (2017) Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death. J Cell Biol 216: 1091– 1105 28254829 PMC5379957
  14. Du J, Cleghorn WM, Contreras L, Lindsay K, Rountree AM, Chertov AO, Turner SJ, Sahaboglu A, Linton J, Sadilek M, Satrustegui J, Sweet IR, Paquet‐Durand F, Hurley JB (2013) Inhibition of mitochondrial pyruvate transport by zaprinast causes massive accumulation of aspartate at the expense of glutamate in the retina. J Biol Chem 288: 36129– 36140 24187136 PMC3861660
  15. Gasteiger E, Hoogland C, Gattiker A, Duvaud SE, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server In The proteomics protocols handbook, Walker JM (ed.), pp 571– 607. New York, NY: Humana Press
  16. Ghosh A, Tyson T, George S, Hildebrandt EN, Steiner JA, Madaj Z, Schulz E, Machiela E, McDonald WG, Escobar Galvis ML, Kordower JH, Van Raamsdonk JM, Colca JR, Brundin P (2016) Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease. Sci Transl Med 8: 368ra174 27928028
  17. Gietz RD, Schiestl RH (2007) High‐efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protoc 2: 31– 34 17401334
  18. Gray LR, Sultana MR, Rauckhorst AJ, Oonthonpan L, Tompkins SC, Sharma A, Fu X, Miao R, Pewa AD, Brown KS, Lane EE, Dohlman A, Zepeda‐Orozco D, Xie J, Rutter J, Norris AW, Cox JE, Burgess SC, Potthoff MJ, Taylor EB (2015) Hepatic mitochondrial pyruvate carrier 1 is required for efficient regulation of gluconeogenesis and whole‐body glucose homeostasis. Cell Metab 22: 669– 681 26344103 PMC4754674
  19. Gray LR, Rauckhorst AJ, Taylor EB (2016) A method for multiplexed measurement of mitochondrial pyruvate carrier activity. J Biol Chem 291: 7409– 7417 26823462 PMC4817172
  20. Halestrap AP, Denton RM (1974) Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by alpha‐cyano‐4‐hydroxycinnamate. Biochem J 138: 313– 316 4822737 PMC1166210
  21. Halestrap AP (1975) The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. Biochem J 148: 85– 96 1156402 PMC1165509
  22. Halestrap AP (1976) The mechanism of the inhibition of the mitochondrial pyruvate transportater by alpha‐cyanocinnamate derivatives. Biochem J 156: 181– 183 942399 PMC1163730
  23. Halestrap AP (2012) The mitochondrial pyruvate carrier: has it been unearthed at last? Cell Metab 16: 141– 143 22883228
  24. Herzig S, Raemy E, Montessuit S, Veuthey JL, Zamboni N, Westermann B, Kunji ER, Martinou JC (2012) Identification and functional expression of the mitochondrial pyruvate carrier. Science 337: 93– 96 22628554
  25. Jones DT, Taylor WR, Thornton JM (1994) A model recognition approach to the prediction of all‐helical membrane protein structure and topology. Biochemistry 33: 3038– 3049 8130217
  26. Klingenberg M (1970) Mitochondria metabolite transport. FEBS Lett 6: 145– 154 11947361
  27. Lee Y, Nishizawa T, Yamashita K, Ishitani R, Nureki O (2015) Structural basis for the facilitative diffusion mechanism by SemiSWEET transporter. Nat Commun 6: 6112 25598322 PMC4309421
  28. Li X, Ji Y, Han G, Li X, Fan Z, Li Y, Zhong Y, Cao J, Zhao J, Zhang M, Wen J, Goscinski MA, Nesland JM, Suo Z (2016) MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer. BMC Cancer 16: 894 27852261 PMC5112705
  29. Li X, Han G, Li X, Kan Q, Fan Z, Li Y, Ji Y, Zhao J, Zhang M, Grigalavicius M, Berge V, Goscinski MA, Nesland JM, Suo Z (2017) Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells. Oncotarget 8: 46363– 46380 28624784 PMC5542273
  30. McCommis KS, Chen Z, Fu X, McDonald WG, Colca JR, Kletzien RF, Burgess SC, Finck BN (2015) Loss of mitochondrial pyruvate carrier 2 in the liver leads to defects in gluconeogenesis and compensation via pyruvate‐alanine cycling. Cell Metab 22: 682– 694 26344101 PMC4598280
  31. McCommis KS, Hodges WT, Bricker DK, Wisidagama DR, Compan V, Remedi MS, Thummel CS, Finck BN (2016) An ancestral role for the mitochondrial pyruvate carrier in glucose‐stimulated insulin secretion. Mol Metab 5: 602– 614 27656398 PMC5021712
  32. Miller CA III, Martinat MA, Hyman LE (1998) Assessment of aryl hydrocarbon receptor complex interactions using pBEVY plasmids: expressionvectors with bi‐directional promoters for use in Saccharomyces cerevisiae. Nucleic Acids Res 26: 3577– 3583 9671822 PMC147745
  33. Nagampalli RSK, Quesnay JEN, Adamoski D, Islam Z, Birch J, Sebinelli HG, Girard R, Ascencao CFR, Fala AM, Pauletti BA, Consonni SR, de Oliveira JF, Silva ACT, Franchini KG, Leme AFP, Silber AM, Ciancaglini P, Moraes I, Dias SMG, Ambrosio ALB (2018) Human mitochondrial pyruvate carrier 2 as an autonomous membrane transporter. Sci Rep 8: 3510 29472561 PMC5823908
  34. Nancolas B, Guo L, Zhou R, Nath K, Nelson DS, Leeper DB, Blair IA, Glickson JD, Halestrap AP (2016) The anti‐tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters. Biochem J 473: 929– 936 26831515 PMC4814305
  35. Nanjan MJ, Mohammed M, Prashantha Kumar BR, Chandrasekar MJN (2018) Thiazolidinediones as antidiabetic agents: a critical review. Bioorg Chem 77: 548– 567 29475164
  36. Nath K, Guo L, Nancolas B, Nelson DS, Shestov AA, Lee SC, Roman J, Zhou R, Leeper DB, Halestrap AP, Blair IA, Glickson JD (2016) Mechanism of antineoplastic activity of lonidamine. Biochem Biophys Acta 1866: 151– 162 27497601 PMC5138080
  37. Ohashi T, Eguchi H, Kawamoto K, Konno M, Asai A, Colvin H, Ueda Y, Takaoka H, Iwagami Y, Yamada D, Asaoka T, Noda T, Wada H, Gotoh K, Kobayashi S, Koseki J, Satoh T, Ogawa K, Doki Y, Mori M et al (2018) Mitochondrial pyruvate carrier modulates the epithelial‐mesenchymal transition in cholangiocarcinoma. Oncol Rep 39: 1276– 1282 29286150
  38. Papa S, Francavilla A, Paradies G, Meduri B (1971) The transport of pyruvate in rat liver mitochondria. FEBS Lett 12: 285– 288 11945601
  39. Papa S, Paradies G (1974) On the mechanism of translocation of pyruvate and other monocarboxylic acids in rat‐liver mitochondria. Eur J Biochem 49: 265– 274 4459142
  40. Paradies G, Papa S (1975) The transport of monocarboxylic oxoacids in rat liver mitochondria. FEBS Lett 52: 149– 152 1123077
  41. Quansah E, Peelaerts W, Langston JW, Simon DK, Colca J, Brundin P (2018) Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration. Mol Neurodegener 13: 28 29793507 PMC5968614
  42. Schell JC, Wisidagama DR, Bensard C, Zhao H, Wei P, Tanner J, Flores A, Mohlman J, Sorensen LK, Earl CS, Olson KA, Miao R, Waller TC, Delker D, Kanth P, Jiang L, DeBerardinis RJ, Bronner MP, Li DY, Cox JE et al (2017) Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nat Cell Biol 19: 1027– 1036 28812582 PMC6137334
  43. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Soding J, Thompson JD, Higgins DG (2011) Fast, scalable generation of high‐quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7: 539 21988835 PMC3261699
  44. Slotboom DJ, Duurkens RH, Olieman K, Erkens GB (2008) Static light scattering to characterize membrane proteins in detergent solution. Methods 46: 73– 82 18625320
  45. Soccio RE, Chen ER, Lazar MA (2014) Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab 20: 573– 591 25242225 PMC4192012
  46. Thangaratnarajah C, Ruprecht JJ, Kunji ERS (2014) Calcium‐induced conformational changes of the regulatory domain of human mitochondrial aspartate/glutamate carriers. Nat Commun 5: 5491 25410934 PMC4250520
  47. Vadvalkar SS, Matsuzaki S, Eyster CA, Giorgione JR, Bockus LB, Kinter CS, Kinter M, Humphries KM (2017) Decreased mitochondrial pyruvate transport activity in the diabetic heart: role of mitochondrial pyruvate carrier 2 (MPC2) acetylation. J Biol Chem 292: 4423– 4433 28154187 PMC5377762
  48. Vanderperre B, Bender T, Kunji ER, Martinou JC (2015) Mitochondrial pyruvate import and its effects on homeostasis. Curr Opin Cell Biol 33: 35– 41 25463844
  49. Vanderperre B, Cermakova K, Escoffier J, Kaba M, Bender T, Nef S, Martinou JC (2016) MPC1‐like is a placental mammal‐specific mitochondrial pyruvate carrier subunit expressed in postmeiotic male germ cells. J Biol Chem 291: 16448– 16461 27317664 PMC4974360
  50. Vigueira PA, McCommis KS, Schweitzer GG, Remedi MS, Chambers KT, Fu X, McDonald WG, Cole SL, Colca JR, Kletzien RF, Burgess SC, Finck BN (2014) Mitochondrial pyruvate carrier 2 hypomorphism in mice leads to defects in glucose‐stimulated insulin secretion. Cell Rep 7: 2042– 2053 24910426 PMC4074444
  51. Wen J, Arakawa T, Philo JS (1996) Size‐exclusion chromatography with on‐line light‐scattering, absorbance, and refractive index detectors for studying proteins and their interactions. Anal Biochem 240: 155– 166 8811899
  52. Xu Y, Tao Y, Cheung LS, Fan C, Chen LQ, Xu S, Perry K, Frommer WB, Feng L (2014) Structures of bacterial homologues of SWEET transporters in two distinct conformations. Nature 515: 448– 452 25186729 PMC4300204
  53. Yang C, Ko B, Hensley CT, Jiang L, Wasti AT, Kim J, Sudderth J, Calvaruso MA, Lumata L, Mitsche M, Rutter J, Merritt ME, DeBerardinis RJ (2014) Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol Cell 56: 414– 424 25458842 PMC4268166
  54. Zahlten RN, Hochberg AA, Stratman FW, Lardy HA (1972) Pyruvate uptake in rat liver mitochondria: transport or adsorption? FEBS Lett 21: 11– 13 11946462
  55. Zhong Y, Li X, Yu D, Li X, Li Y, Long Y, Yuan Y, Ji Z, Zhang M, Wen JG, Nesland JM, Suo Z (2015) Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem‐like properties in LnCap prostate cancer cells in vitro. Oncotarget 6: 37758– 37769 26413751 PMC4741963

Cited by

Sorted by citations

Authors
Tavoulari, S., Thangaratnarajah, C., Mavridou, V., Harbour, M. E., Martinou, J., & Kunji, E. R.
Affiliations
  • University of Cambridge (GB)
  • University of Geneva (CH)
Corresponding author
  • Tavoulari, Sotiria
  • Kunji, Edmund RS
Venue
The EMBO Journal
Published
2019-04-12
Volume
38
Issue
10
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2939652298
Cited by
73
References
4
Citations by year
2026: 7 · 2025: 14 · 2024: 7 · 2023: 7 · 2022: 6 · 2021: 10 · 2020: 18 · 2019: 4
FWCI
3.11
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Funders
  • RCUK | Medical Research Council (MC_UU_00015/1)
  • Oncosuisse (KFS‐4434‐02‐2018)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_179421/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
Keywords
mitochondrial pyruvate carrier, pyruvate transport, heterodimer, oligomeric state, Saccharomyces cerevisiae, MPC1, MPC2, substrate transport mechanism, mitochondrial matrix
MeSH terms
Saccharomyces cerevisiae, Structure-Activity Relationship, Temperature, Gene Expression Regulation, Fungal, Pyruvic Acid, Protein Structure, Quaternary, Anion Transport Proteins, Monocarboxylic Acid Transporters, Saccharomyces cerevisiae Proteins, Organisms, Genetically Modified, Mitochondrial Membrane Transport Proteins, Multiprotein Complexes, Protein Multimerization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review